Cite
MLA Citation
Noriyuki Kijima et al.. “ACT-20 PHASE 1/2, PROSPECTIVE, INTERNATIONAL MULTI-CENTER STUDY TO ESTABLISH THE SAFETY AND FEASIBILITY OF BLOOD-BRAIN-BARRIER DISRUPTION COMBINED WITH CARBOPLATIN FOR RECURRENT GLIOBLASTOMA; FIRST CLINICAL EXPERIENCE IN JAPAN.” Neuro-oncology advances, vol. 4, n.d., p. iii9. http://access.bl.uk/ark:/81055/vdc_100171887941.0x000005